FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical composition for topical treatment of herpes-zostere virus and type 1 herpes simplex virus infections. Claimed composition contains as virus static agent (E)-5-(2-bromovinyl)-2'-deoxyuridine (Brivudine) and photostabilizer selected from group containing carothenoids and benzophenone derivatives, and phenylazobenzene.
EFFECT: pharmaceutical composition with high stability against photodegradation.
6 cl, 17 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BRIVUDINE STABILIZED PREPARATIONS FOR TOPICAL USING | 2002 |
|
RU2280453C2 |
| KERATIN-BINDING POLYPEPTIDES | 2005 |
|
RU2411029C9 |
| NOVEL INDANYLIDENE COMPOUNDS | 2001 |
|
RU2290397C2 |
| STABILISED COMPOSITIONS FOR LOCAL APPLICATION, CONTAINING KETOPROFEN | 2004 |
|
RU2340335C2 |
| SKIN-CLARIFYING COMPOSITION | 1999 |
|
RU2229294C2 |
| ESTER COMPOUNDS OF BENZOIC ACID, COMPOSITION (VERSIONS) AND METHOD OF COMPOSITION (VERSIONS) OBTAINING | 2006 |
|
RU2485936C2 |
| LOCAL FINISHED PREPARATIVE FORM CONTAINIG KETOPROFEN STABILISED WITH SULYSOBENZONE | 2003 |
|
RU2328281C2 |
| POLYMER COMPOSITION ABSORBING ULTRAVIOLET RADIATION | 2017 |
|
RU2764196C2 |
| COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING MEROCYANINE DERIVATIVE, WHICH INCLUDES SPECIFIC POLAR GROUPS CONSISTING OF A HYDROXYL AND ETHER FUNCTIONAL GROUPS | 2012 |
|
RU2609859C2 |
| GEL-BASED HAIR TINT COLORING | 2017 |
|
RU2654015C1 |
